RADIO-FREQUENCY ELECTRICAL MEMBRANE BREAKDOWN FOR THE TREATMENT OF HIGH RISK AND RECURRENT PROSTATE CANCER, UNRESECTABLE PANCREATIC CANCER, TUMORS OF THE BREAST, MELANOMA OR OTHER SKIN MALIGNANCIES, SARCOMA, SOFT TISSUE TUMORS, DUCTAL CARCINOMA, NEOPLASIA, AND INTRA AND EXTRA LUMINAL ABNORMAL TISSUE

摘要

An imaging, guidance, planning and treatment system integrated into a single unit or assembly of components, and a method for using same, that can be safely and effectively deployed to treat prostate cancer, unresectable pancreatic cancer, tumors of the breast or soft tissue, including those located in the head, neck, central nervous system or brain, melanoma, ductal carcinoma, neoplasia, or intra and extra luminal abnormal tissue. The system utilizes the novel process of Radio-Frequency Electrical Membrane Breakdown ("EΜΒ" or "RFEMB") to destroy the cellular membranes of unwanted or cancerous tissue without denaturing the intra- cellular contents of the cells comprising the tissue, thereby ablating it and exposing tumor antigens and oilier intra-cellular components which can have an immunologic effect on local or distant cancerous tissue., with or without the addition of immunologic adjuvant, drugs., agents, or materials. The system preferably comprises at least one EMB treatment probe (20), at least one trackable biopsy needle (200), at least one trackable anesthesia needle (300), and at least one controller unit for at least partially automating the treatment process.